PortfoliosLab logo
LHX vs. ABT
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between LHX and ABT is 0.49, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.5

Performance

LHX vs. ABT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in L3Harris Technologies, Inc. (LHX) and Abbott Laboratories (ABT). The values are adjusted to include any dividend payments, if applicable.

10,000.00%15,000.00%20,000.00%25,000.00%30,000.00%NovemberDecember2025FebruaryMarchApril
10,245.37%
29,052.77%
LHX
ABT

Key characteristics

Sharpe Ratio

LHX:

0.28

ABT:

1.13

Sortino Ratio

LHX:

0.54

ABT:

1.71

Omega Ratio

LHX:

1.07

ABT:

1.22

Calmar Ratio

LHX:

0.23

ABT:

0.91

Martin Ratio

LHX:

0.49

ABT:

5.64

Ulcer Index

LHX:

12.27%

ABT:

4.13%

Daily Std Dev

LHX:

21.94%

ABT:

20.59%

Max Drawdown

LHX:

-65.58%

ABT:

-45.66%

Current Drawdown

LHX:

-17.31%

ABT:

-7.30%

Fundamentals

Market Cap

LHX:

$40.60B

ABT:

$228.46B

EPS

LHX:

$7.92

ABT:

$7.63

PE Ratio

LHX:

27.31

ABT:

17.02

PEG Ratio

LHX:

0.32

ABT:

4.17

PS Ratio

LHX:

1.90

ABT:

5.40

PB Ratio

LHX:

2.08

ABT:

4.79

Total Revenue (TTM)

LHX:

$16.11B

ABT:

$31.99B

Gross Profit (TTM)

LHX:

$3.98B

ABT:

$17.78B

EBITDA (TTM)

LHX:

$2.83B

ABT:

$8.53B

Returns By Period

In the year-to-date period, LHX achieves a 3.41% return, which is significantly lower than ABT's 15.52% return. Both investments have delivered pretty close results over the past 10 years, with LHX having a 12.60% annualized return and ABT not far ahead at 12.69%.


LHX

YTD

3.41%

1M

1.75%

6M

-10.52%

1Y

6.26%

5Y*

4.76%

10Y*

12.60%

ABT

YTD

15.52%

1M

3.49%

6M

12.12%

1Y

23.47%

5Y*

8.52%

10Y*

12.69%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

LHX vs. ABT — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LHX
The Risk-Adjusted Performance Rank of LHX is 5858
Overall Rank
The Sharpe Ratio Rank of LHX is 6464
Sharpe Ratio Rank
The Sortino Ratio Rank of LHX is 5353
Sortino Ratio Rank
The Omega Ratio Rank of LHX is 5252
Omega Ratio Rank
The Calmar Ratio Rank of LHX is 6464
Calmar Ratio Rank
The Martin Ratio Rank of LHX is 5858
Martin Ratio Rank

ABT
The Risk-Adjusted Performance Rank of ABT is 8484
Overall Rank
The Sharpe Ratio Rank of ABT is 8787
Sharpe Ratio Rank
The Sortino Ratio Rank of ABT is 8282
Sortino Ratio Rank
The Omega Ratio Rank of ABT is 7979
Omega Ratio Rank
The Calmar Ratio Rank of ABT is 8383
Calmar Ratio Rank
The Martin Ratio Rank of ABT is 8989
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

LHX vs. ABT - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for L3Harris Technologies, Inc. (LHX) and Abbott Laboratories (ABT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for LHX, currently valued at 0.28, compared to the broader market-2.00-1.000.001.002.003.00
LHX: 0.28
ABT: 1.13
The chart of Sortino ratio for LHX, currently valued at 0.54, compared to the broader market-6.00-4.00-2.000.002.004.00
LHX: 0.54
ABT: 1.71
The chart of Omega ratio for LHX, currently valued at 1.07, compared to the broader market0.501.001.502.00
LHX: 1.07
ABT: 1.22
The chart of Calmar ratio for LHX, currently valued at 0.23, compared to the broader market0.001.002.003.004.005.00
LHX: 0.23
ABT: 0.91
The chart of Martin ratio for LHX, currently valued at 0.49, compared to the broader market-10.00-5.000.005.0010.0015.0020.00
LHX: 0.49
ABT: 5.64

The current LHX Sharpe Ratio is 0.28, which is lower than the ABT Sharpe Ratio of 1.13. The chart below compares the historical Sharpe Ratios of LHX and ABT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.002.503.00NovemberDecember2025FebruaryMarchApril
0.28
1.13
LHX
ABT

Dividends

LHX vs. ABT - Dividend Comparison

LHX's dividend yield for the trailing twelve months is around 2.16%, more than ABT's 1.76% yield.


TTM20242023202220212020201920182017201620152014
LHX
L3Harris Technologies, Inc.
2.16%2.21%2.17%2.15%1.91%1.80%1.45%1.86%1.55%2.01%2.23%2.48%
ABT
Abbott Laboratories
1.76%1.95%1.85%1.71%1.28%1.32%1.47%1.55%1.86%2.71%2.14%1.95%

Drawdowns

LHX vs. ABT - Drawdown Comparison

The maximum LHX drawdown since its inception was -65.58%, which is greater than ABT's maximum drawdown of -45.66%. Use the drawdown chart below to compare losses from any high point for LHX and ABT. For additional features, visit the drawdowns tool.


-25.00%-20.00%-15.00%-10.00%-5.00%0.00%NovemberDecember2025FebruaryMarchApril
-17.31%
-7.30%
LHX
ABT

Volatility

LHX vs. ABT - Volatility Comparison

L3Harris Technologies, Inc. (LHX) has a higher volatility of 9.61% compared to Abbott Laboratories (ABT) at 8.99%. This indicates that LHX's price experiences larger fluctuations and is considered to be riskier than ABT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


3.00%4.00%5.00%6.00%7.00%8.00%9.00%10.00%NovemberDecember2025FebruaryMarchApril
9.61%
8.99%
LHX
ABT

Financials

LHX vs. ABT - Financials Comparison

This section allows you to compare key financial metrics between L3Harris Technologies, Inc. and Abbott Laboratories. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items